What's new
Researchers at the University of Helsinki, Universidade Católica Portuguesa, CBQF, and Technische Universität Dresden, Institute of Hydrobiology, along with other collaborators have performed the first trans-Europe surveillance study on antibiotic resistance utilizing the SmartChip Real-Time PCR System.
05/16/2019
Learn more about how researchers used our ICELL8 Single-Cell System to develop a novel single-cell ATAC-seq workflow.
05/07/2019
Learn how SMARTer RNA-seq and PrimeSTAR GXL polymerase helped identify transcription factors involved in cardiomyocyte heterogeneity.
04/29/2019
What criteria should you consider when developing reliable and translationally relevant disease models from edited hiPSCs?
04/16/2019
Research spotlight
The immune system doesn't innately recognize that cancer cells are abnormal, but now researchers can genetically modify a person's own immune cells to attack cancer cells. This type of immunotherapy is recognized as a promising strategy for the treatment of a variety of cancers...and that's Good Science!
Good science begins with selecting the right methods and reagents, especially when research targets are challenging. In this work, cancer researchers developed a method to amplify challenging BRCA targets, including those that are GC-rich or over 13 kb in length, using two-step PCR under a single set of conditions.
ASMS 2019 will bring together research and industry experts to discuss advancements in mass spectrometry technologies.
ESHG gathers scientists from around the globe to discuss the latest in human genetics.
WPC brings together research, clinical, and industry experts to discuss the state and advances of preclinical research and technologies.
©2019 Takara Bio Inc. All Rights Reserved.
Region - North America Privacy Policy Terms and Conditions Terms of Use
Creating cancer killers
The immune system doesn't innately recognize that cancer cells are abnormal, but now researchers can genetically modify a person's own immune cells to attack cancer cells. This type of immunotherapy is recognized as a promising strategy for the treatment of a variety of cancers...and that's Good Science!
Optimizing materials and methods for cancer research
Good science begins with selecting the right methods and reagents, especially when research targets are challenging. In this work, cancer researchers developed a method to amplify challenging BRCA targets, including those that are GC-rich or over 13 kb in length, using two-step PCR under a single set of conditions.
Read about how the researchers developed their long-range PCR protocol for BRCA1 and BRCA2
